Alamar Biosciences, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Yuling Luo has reported beneficial ownership of 6.4% of Alamar Biosciences' common stock as of June 30, 2026, including exercisable options and shares held by spouse.
NASDAQ
SCHEDULE: Qiming Entities File Joint Schedule 13G
Several Qiming entities have entered into a joint filing agreement to collectively report their beneficial ownership of Alamar Biosciences, Inc. common stock.
NASDAQ
Sherpa Healthcare Fund II, L.P. and Sherpa Healthcare Co-Investment Fund, L.P., along with Daqing Cai, have reported beneficial ownership of 7.2% of Alamar Biosciences, Inc. common stock.